Detalles de la búsqueda
1.
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study.
Oncologist
; 29(3): e372-e381, 2024 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37796838
2.
Successful treatment with selpercatinib after pralsetinib-related pneumonitis and intracranial failure in a patient with RET-rearranged nonsmall cell lung cancer.
Anticancer Drugs
; 35(6): 559-562, 2024 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38453158
3.
The role of blood cholesterol quality in patients with advanced cancer receiving immune checkpoint inhibitors.
Cancer Immunol Immunother
; 72(7): 2127-2135, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36828963
4.
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort.
J Transl Med
; 19(1): 270, 2021 06 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34167578
5.
Modulating Tumor Microenvironment: A Review on STK11 Immune Properties and Predictive vs Prognostic Role for Non-small-cell Lung Cancer Immunotherapy.
Curr Treat Options Oncol
; 22(11): 96, 2021 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34524570
6.
Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer.
Drug Resist Updat
; 46: 100644, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31585395
7.
The Role of c-Met as a Biomarker and Player in Innate and Acquired Resistance in Non-Small-Cell Lung Cancer: Two New Mutations Warrant Further Studies.
Molecules
; 24(24)2019 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31817278
8.
Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors.
Pharmacol Res
; 127: 15-25, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28964914
9.
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations.
Clin Exp Metastasis
; 41(2): 117-129, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38363410
10.
Exploring genetic and immune underpinnings of the sexual dimorphism in tumor response to immune checkpoints inhibitors: A narrative review.
Curr Res Pharmacol Drug Discov
; 4: 100146, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36571078
11.
Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario.
Technol Cancer Res Treat
; 22: 15330338231159753, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36855829
12.
The radiological appearances of lung cancer treated with immunotherapy.
Br J Radiol
; 96(1144): 20210270, 2023 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36367539
13.
Role of Clock Genes and Circadian Rhythm in Renal Cell Carcinoma: Recent Evidence and Therapeutic Consequences.
Cancers (Basel)
; 15(2)2023 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36672355
14.
Thirty-day mortality in hospitalised patients with lung cancer: incidence and predictors.
BMJ Support Palliat Care
; 2023 Sep 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37666650
15.
Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic Score.
Front Biosci (Elite Ed)
; 15(3): 20, 2023 07 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37743233
16.
Can we identify a preferred first-line strategy for sarcomatoid renal cell carcinoma? A network meta-analysis.
Immunotherapy
; 14(2): 145-153, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34806404
17.
Integrated MRI-Immune-Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma.
Cancers (Basel)
; 14(13)2022 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35805021
18.
PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors.
Tumori
; 108(1): 47-55, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34002648
19.
Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma.
Biomedicines
; 10(10)2022 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36289706
20.
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients.
Tumori
; 108(1): 86-92, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33730957